The Dana-Farber Cancer Institute
Patients diagnosed with cancer have many questions about their illness, treatment options and how the disease will take a toll on them physically and emotionally. At the Eleanor and Maxwell Blum Patient and Family Resource Center, patients and their family members can find information on:
- Clinical research
- Stress management
- Controlling pain
- Explaining cancer to children
- Hospice care
- Employment discrimination
The Dana-Farber/ Brigham and Women’s Cancer Center mixes the focus of a leading cancer center and the resources of a major hospital to provide comprehensive care for adults burdened with cancer. With outpatient care handled at Dana-Farber, and inpatient care taking place at Brigham and Women’s Hospital. Connected by a bridge, and the commitment to medical excellence, the hospitals work together to offer cancer patients state-of-the-art treatment.
With programs that foster healing and educating, the Dana- Farber Yawkey Center for Cancer Care offers numerous amenities and features to ease the weight of a cancer diagnosis for patients and families.
The Lowe Center for Thoracic Oncology treats lung cancer, mesothelioma and other cancers localized in the chest wall. The physicians work together to provide a patient with comprehensive care, helping patients throughout each stage of treatment and supporting them and their families.
Diseases treated at the Lowe center for Thoracic Oncology include:
- Lung cancer
- Mediastinal cancer
- Metastatic tumors to the lungs
- Non-small cell cancer
- Pleural cancer
- Respiratory system cancers
- Small cell cancer
- Tracheal cancer
- Thymus/mediastinal cancer
- Tumors of the chest wall
The cancer institute has made many advances in research development. Teams at the institute have identified overactive genes in aggressive breast cancer, associated biomarkers activation with improved survival in patients with colorectal cancer and developed a technique that extends cancer-fighting cells’ potency in melanoma patients. Additionally, scientists’ research at Dana-Farber Institute has identified a promising target for AIDS vaccine.
Awards and Honors
With a dedication toward cancer research, and excellence in compassionate patient care, it is no wonder why Dana-Farber Cancer Institute has received many awards and honors. For one, Sylvia Bartel, Vice President of Pharmacy was named 2010 President’s Pharmacist of the Year by the Massachusetts Pharmacists Association.
Director of the Jerome Lipper Multiple Myeloma Center and LeBow Institute for Myeloma Therapeutics at Dana-Farber, Kenneth Anderson, MD, has become one of 65 newly elected members to the Institute of Medicine. This institute advises the government on health and science policy.
In September of 2010, the Dana-Farber Cancer Institute completed their biggest campaign to date. Mission Possible: The Dana-Farber Campaign to Conquer Cancer raised $ 1.18 billion dollars making Dana-Farber the first hospital in New England to launch and complete a $1 billion dollar capital campaign.